cover of episode Vaccine in Sight, What Now for Stocks?

Vaccine in Sight, What Now for Stocks?

2020/11/9
logo of podcast Halftime Report

Halftime Report

Shownotes Transcript

Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks?